With an annual growth rate of 6.6 percent, the global calcium carbonate market is seeing increasing demand for paper from packaging applications and hygiene-related products. BioTech Medics, Inc. (OTC PINK:BMCS) announced in a press release today the acquisition of significant organic calcium carbonate assets and the intention to begin supplying the industry with calcium and produce a number of products to generate revenue. The firm also said that going forward its business model will focus on calcium, silica and carbon credits.
Last month, company management traveled to the Dominican Republic to meet and finalize an agreement in which BMCS acquired 2 million metric tonnes of medical-grade calcium carbonate with an option on another 48 million tonnes in the future. Shares were trading at $0.024 in morning trade.
Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
]]>